A lthough the contractile performance of the myocardium is under continuous nervous and hormonal regulation, the myocardium possesses a number of intrinsic, load-dependent mechanisms by which it can adjust cardiac output to meet the needs of the circulation over periods ranging from seconds to years. In isolated hearts, an increase in ventricular end-diastolic volume (EDV), produced by increased venous return or decreased aortic outflow, leads immediately to a more powerful contraction via the FrankStarling mechanism ("heterometric autoregulation" 1 ), so that cardiac output increases over a few beats to match venous return. However, over the next few minutes, there is a further increase in myocardial performance, such that EDV returns toward its original value. This second autoregulatory mechanism, the "Anrep effect" 2 or "homeometric autoregulation," 1 allows a given change in cardiac output to be achieved with a smaller change in EDV than if the Frank-Starling effect were the only compensatory mechanism. Finally, if the increase in EDV or wall stress is maintained, genes are switched on that eventually lead to myocardial cell hypertrophy.
The Contractile Response to Stretch of the Myocardium
Our knowledge of the cellular mechanisms involved in the time-dependent increase in contractility after myocardial fiber stretch has come chiefly from studies in which fiber length is controlled (for reviews, see References 4 -6). Parmley and Chuck 7 were the first to show that stretch of isolated papillary muscle leads to a rapid increase in active force (corresponding to the Frank-Starling mechanism in the intact heart), followed by a further increase in force over several minutes (analogous to the Anrep effect). The slow increase in force (here termed the "slow force response") has subsequently been confirmed in a range of isometrically contracting preparations, from isolated myocardial cells 8 to isovolumic hearts in vitro, 9, 10 and in volume-loaded hearts in vivo. 11 The immediate increase in force appears to be due to length-dependent properties of the cardiac myofibrils, chiefly an increase in their sensitivity to [Ca 2ϩ ] i . 4 In contrast, the slow force response can be explained qualitatively 8, 10, 12 and quantitatively 13 by a slow increase in the magnitude of the intracellular Ca 2ϩ transient. However, the mechanism responsible for this slow potentiation of the Ca 2ϩ transient has remained obscure. It cannot be explained by a length dependence of sarcoplasmic reticulum (SR) Ca 2ϩ handling itself, because the slow force response remains in the presence of specific SR inhibitors. [13] [14] [15] Other mechanisms could involve the observed stretch-induced increases in second messengers such as cAMP 10 extrusion from the cell during diastole via forward-mode Na ϩ /Ca 2ϩ exchange, and raise Ca 2ϩ entry during the action potential via reverse-mode Na ϩ /Ca 2ϩ exchange. Stimulation of the NHE has been implicated in the positive inotropic actions of Ang II and ET-1 (reviewed in Reference 19), but evidence that the NHE and these hormones may play a part in the responses of the myocardium to stretch has come from another area of cardiac research: the triggering of cellular hypertrophy by stretch.
The Hypertrophic Response to Stretch of the Myocardium
The past decade has seen major advances in our understanding of the events that couple myocardial stretch to cellular hypertrophy. Changes triggered by stretch of myocardial cells include the activation of "intermediate-early" genes, such as c-fos, followed by "late-responsive" genes such as fetal contractile protein genes (eg, those for ␤-myosin and skeletal ␣-actinin). Multiple signal transduction pathways are activated, including phospholipases C, D, and A 2 , and many types of protein kinase, including protein kinase C, tyrosine kinase, and the Raf-1 and mitogen-activated protein kinase (MAPK) cascades. 20 -22 The initial response to stretch is rapid: intermediate-early genes and the signaling pathways are switched on within minutes, ie, on the same time scale as the slow force response. These changes may be due, at least in part, to the stretch-induced activation of local (ie, intracardiac) autocrine systems. It is known that myocardial cells possess local renin-angiotensin 23 and endothelin systems. 24 Using neonatal rat ventricular myocytes cultured on an elastic silicone substrate, it has been shown that stretch stimulates secretion of Ang II 20 -22,25 and ET-1 22, 25 and that released Ang II alone, 20 or both hormones, 22, 25 induces activation of MAPK, c-fos, etc. The importance of these autocrine systems in the intact adult heart is less clear, because adult cells have a different expression of genes and a different complement of receptors compared with neonatal cells. In addition, the myocardium possesses endothelial cells and fibroblasts, both of which may release Ang II or ET-1 in response to stretch and so could influence myocardial gene expression via a paracrine mechanism. In vivo, the situation is even more complex, and the hypertrophic effects of other factors such as sympathetic stimulation may become dominant. 26 The local stretch-induced release of Ang II or ET-1 by the autocrine/paracrine pathways might be expected to stimulate the NHE, given that exogenous Ang II or ET-1 will do this. Indeed, Yamazaki et al 22 recently demonstrated a stretchinduced activation of the NHE that triggered a hypertrophic response via an increase of pH i , although unexpectedly this effect appeared to be independent of autocrinely released Ang II or ET-1. Cingolani's group has now linked the contractile and molecular effects of myocardial cell stretch, by demonstrating a stretch-induced activation of the NHE that may account for the slow force response.
The Role of the NHE in the Slow Force Response to Muscle Stretch
If stretch activates the NHE, this should tend to increase pH i and [Na ϩ ] i . Cingolani et al 27 found previously that stretch of cat papillary muscle did indeed produce a rise of pH i over Ϸ10 minutes. This alkalosis was due to the activation of the NHE, as it was abolished by the NHE blocker EIPA. The essential role of Ang II was shown by the demonstration that the alkalosis was also blocked by the AT 1 antagonist losartan. Interestingly, this seemed not to be a direct effect of Ang II on the NHE, given that the rise in pH i produced by stretch (or by exogenous Ang II) was also inhibited by ET-1 antagonists. Cingolani et al 27 suggested that Ang II, released from the papillary muscle (or added exogenously), caused the local release of ET-1, which then activated the NHE, and thereby increased pH i . This agreed with previous studies showing that Ang II could induce the synthesis and/or release of ET-1 from myocardial cells, fibroblasts, or endothelial cells (see References 27 and 28). The conclusions 27 were that stretch of an intact cardiac muscle caused the sequential release of endogenous Ang II and ET-1, both of which thus acted in an autocrine/paracrine role, and that the resulting increase in pH i was mediated by stimulation of the NHE by ET-1.
In the present study, 3 Cingolani's group has extended their work by investigating the contractile consequences of this stretch-induced stimulation of the NHE. Using isolated rat trabeculae, they confirmed that muscle stretch increased pH i (measured from all the cells in the preparation) when the muscle was bathed in HEPES-Tyrode's solution but found that pH i did not change significantly in Tyrode's solution containing CO 2 /HCO 3 Ϫ buffer (perhaps because an acidloading Cl Ϫ /HCO 3 Ϫ exchanger was activated by Ang II). Because the slow force response was the same under both conditions, it was unlikely to be due to the increase in pH i . There was however a marked increase in [Na ϩ ] i after the stretch, with a time course similar to, or perhaps slightly preceding, the rise of force. The role of the NHE in the rise of both [Na ϩ ] i and force was confirmed by the finding that EIPA inhibited the rise in both measurements. The stretchinduced changes in [Na ϩ ] i and force were also reduced by AT 1 or ET-1 antagonists, confirming the primary roles of both hormones in the ionic and contractile changes. The slow increase in the magnitude of the Ca 2ϩ transient was also blocked by these antagonists. Provided that all the antagonists used were acting specifically, the data from both studies 3, 27 lead to the following suggested mechanism for the slow force response: ] i , or increase in pH i ), so one or the other of these might predominate during the inotropic response to stretch or Ang II, depending on the experimental conditions. The precise roles of changes in [Na ϩ ] i , pH i , and of other potential mechanisms in the slow force response to stretch will need to be established by further quantitative studies. In this regard, it may be noted that the muscles used in the study by Alvarez et al 3, 27 were superfused rather than perfused, which might enhance the autocrine/paracrine effects compared with slightly better perfused preparations, such as isolated myocytes and perfused hearts.
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A number of other questions remain, including: Are myocardial cells, endothelial cells, or fibroblasts the primary source of secreted Ang II or ET-1? How does stretch cause the release of Ang II, and what is the mechanosensor (stretch-activated channels, cytoskeleton, etc.)? How exactly is the NHE stimulated by Ang II and/or ET-1, and which kinases are involved upstream and possibly downstream of NHE? Are these mechanisms important in the intact heart? Thus, more work is needed before we can fully understand the precise mechanism(s) by which stretch increases the contractile state of isometrically contracting preparations and working hearts. Nevertheless, the study by Alvarez et al 3 has suggested a novel and important role for a stretch-induced release of Ang II by an autocrine/paracrine mechanism, and for the subsequent stimulation of the NHE, in the contractile response of the myocardium to stretch.
